Here, we investigated the prevalence of ROR1 expression in SCLC patient samples and determined the effectiveness of ROR1 inhibition alone and its potential synergy with BCL2 inhibition in SCLC cell lines. Here, BCL2 is linked to small cell lung carcinoma.